Here's the live share price of Biocon along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Biocon has declined 4.10% CAGR. Over the past year, the corresponding return has been 4.69%.
Biocon’s current P/E of 123.29x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Biocon | 0.60 | 0.17 | -10.55 | 7.19 | 4.69 | 10.42 | -4.10 |
Sun Pharmaceutical Industries | 0.61 | 3.75 | -1.31 | -4.00 | -11.06 | 19.71 | 28.30 |
Divi's Laboratories | 1.82 | 9.01 | -2.79 | 16.99 | 8.54 | 22.59 | 16.36 |
Cipla | 0.74 | 0.89 | 6.11 | 3.80 | 0.95 | 12.39 | 15.54 |
Torrent Pharmaceuticals | 0.79 | 0.61 | 1.73 | 9.53 | 4.97 | 31.14 | 21.67 |
Dr. Reddy's Laboratories | -0.59 | -4.09 | -0.47 | 8.04 | -6.16 | 13.20 | 4.47 |
Mankind Pharma | 0.79 | -3.52 | -6.15 | -4.04 | -7.61 | 20.28 | 11.72 |
Zydus Lifesciences | -0.62 | -4.59 | 0.54 | 18.75 | -3.29 | 33.10 | 18.50 |
Lupin | -1.21 | -4.69 | -0.99 | -0.04 | -11.08 | 40.99 | 13.81 |
Alkem Laboratories | 2.52 | 2.09 | 11.49 | 12.91 | -7.17 | 21.39 | 16.09 |
Aurobindo Pharma | -2.60 | 0.45 | -4.57 | -6.04 | -25.00 | 28.42 | 6.59 |
Abbott India | -1.13 | -3.60 | -12.58 | -2.76 | 4.99 | 18.17 | 13.51 |
Glenmark Pharmaceuticals | -3.81 | -8.65 | -16.23 | 39.03 | 7.51 | 67.86 | 31.37 |
Laurus Labs | 2.78 | 0.87 | 9.70 | 43.66 | 93.21 | 20.69 | 22.11 |
GlaxoSmithKline Pharmaceuticals | -0.62 | 0.42 | -13.35 | -5.58 | 3.60 | 26.00 | 12.58 |
Anthem Biosciences | -5.27 | -12.22 | 3.79 | 3.79 | 3.79 | 1.25 | 0.75 |
Cohance Lifesciences | -1.85 | -8.23 | -18.75 | -23.96 | -28.98 | 31.15 | 21.02 |
Ipca Laboratories | -3.35 | -1.70 | -12.53 | -7.89 | -21.82 | 13.02 | 4.25 |
Gland Pharma | 0.74 | -2.60 | -3.58 | 33.69 | 18.08 | -3.50 | 1.24 |
Ajanta Pharma | 0.03 | -4.94 | -12.69 | -9.65 | -24.94 | 24.63 | 18.77 |
Over the last one year, Biocon has gained 4.69% compared to peers like Sun Pharmaceutical Industries (-11.06%), Divi's Laboratories (8.54%), Cipla (0.95%). From a 5 year perspective, Biocon has underperformed peers relative to Sun Pharmaceutical Industries (28.30%) and Divi's Laboratories (16.36%).
Day | SMA | EMA |
---|---|---|
5 | 352.57 | 354.41 |
10 | 350.55 | 352.81 |
20 | 352.68 | 353.32 |
50 | 356.99 | 356.95 |
100 | 360.29 | 356.92 |
200 | 353.41 | 352.08 |
In the latest quarter, Biocon remained same as its previous close in promoter holding, while DII stake increased to 22.83%, FII holding fell to 6.04%, and public shareholding moved down to 16.51% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
2,88,07,465 | 2.08 | 982.33 | |
1,39,69,697 | 2.14 | 476.37 | |
1,30,00,000 | 1.56 | 443.3 | |
83,30,203 | 0.6 | 284.06 | |
72,99,915 | 2.94 | 248.93 | |
58,62,280 | 1.64 | 199.9 | |
56,80,217 | 3.11 | 193.7 | |
47,19,374 | 1.98 | 160.93 | |
36,46,511 | 1.05 | 124.35 | |
35,18,645 | 0.22 | 119.99 |
* Excluding Index & Arbitrage Funds
Price | (%) As on Invalid Date IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Date Time | Announcement |
---|---|
Oct 16, 2025, 9:13 PM IST | Biocon - Press Release |
Oct 14, 2025, 12:00 AM IST | Biocon - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Oct 12, 2025, 2:12 AM IST | Biocon - Company Statement |
Oct 09, 2025, 10:19 PM IST | Biocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Oct 09, 2025, 6:50 PM IST | Biocon - Submission Of Copy Of Biocon India Limited Employees Welfare Trust Amendment Deed |
Biocon Ltd. is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2242.60 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Biocon is ₹355.00 as on Oct 17, 2025.
The Biocon is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Biocon is ₹47,462.21 Cr as on Oct 17, 2025.
Today’s highest and lowest price of Biocon are ₹361.15 and ₹354.95.
The 52-week high/low is the highest and lowest price at which Biocon stock has traded in the past 52-week or nearly a year. The 52-week high of Biocon is ₹405.90 and 52-week low of Biocon is ₹290.80 as on Oct 17, 2025.
The Biocon has shown returns of -0.87% over the past day, 0.17% for the past month, -10.55% over 3 months, 4.69% over 1 year, 10.42% across 3 years, and -4.1% over 5 years.
P/E ratio of and PB ratio of Biocon are 123.29 and 2.25 on Oct 17, 2025. While the company gives a dividend yield of 0.14 per annum.